載入...
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
A Phase 1 study was conducted in 24 malaria naïve adults to assess the safety and immunogenicity of the recombinant protein vaccine Apical Membrane Antigen 1-Combination 1 (AMA1-C1)/Alhydrogel with CPG 7909 in two different formulations (phosphate buffer and saline), and given at two different dosin...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2722923/ https://ncbi.nlm.nih.gov/pubmed/19410624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.04.077 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|